BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fritzler MJ, Mahler M. Redefining systemic lupus erythematosus - SMAARTT proteomics. Nat Rev Rheumatol 2018;14:451-2. [PMID: 29907860 DOI: 10.1038/s41584-018-0035-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Chin A, Choi MY, Fritzler MJ. Gaps and Trends in Autoantibody Testing. J Appl Lab Med 2022;7:362-6. [PMID: 34996094 DOI: 10.1093/jalm/jfab153] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Martin-Gutierrez L, Peng J, Thompson NL, Robinson GA, Naja M, Peckham H, Wu W, J'bari H, Ahwireng N, Waddington KE, Bradford CM, Varnier G, Gandhi A, Radmore R, Gupta V, Isenberg DA, Jury EC, Ciurtin C. Stratification of Patients With Sjögren's Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications. Arthritis Rheumatol 2021;73:1626-37. [PMID: 33645922 DOI: 10.1002/art.41708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fritzler MJ, Choi MY, Satoh M, Mahler M. Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond. Front Immunol 2021;12:679613. [PMID: 34122443 DOI: 10.3389/fimmu.2021.679613] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Fritzler MJ. Professional Insights from a Pioneer in Autoimmune Disease Testing: The Future of Antinuclear/Anticellular Antibody Testing. J Appl Lab Med 2019;4:287-9. [PMID: 31639678 DOI: 10.1373/jalm.2018.028399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Conrad K, Shoenfeld Y, Fritzler MJ. Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases. Autoimmun Rev 2020;19:102508. [PMID: 32173518 DOI: 10.1016/j.autrev.2020.102508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
6 Choi MY, Fritzler MJ. Autoantibodies in SLE: prediction and the p value matrix. Lupus 2019;28:1285-93. [PMID: 31399014 DOI: 10.1177/0961203319868531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
7 Choi MY, Fritzler MJ. Challenges and Advances in SLE Autoantibody Detection and Interpretation. Curr Treat Options in Rheum 2019;5:147-67. [DOI: 10.1007/s40674-019-00122-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lockshin MD, Barbhaiya M, Izmirly P, Buyon JP, Crow MK. SLE: reconciling heterogeneity. Lupus Sci Med 2019;6:e000280. [PMID: 31080630 DOI: 10.1136/lupus-2018-000280] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fritzler MJ, Martinez-Prat L, Choi MY, Mahler M. The Utilization of Autoantibodies in Approaches to Precision Health. Front Immunol 2018;9:2682. [PMID: 30505311 DOI: 10.3389/fimmu.2018.02682] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]